Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-86.92M -76.41M -58.76M -35.25M
Depreciation & Amortization
1.22M 1.29M 1.18M 831K
Stock-Based Compensation
11.72M 8.77M 6.41M 2.31M
Other Working Capital
-3.12M 5.48M -3.44M -1.37M
Other Non-Cash Items
-3.19M -1.95M -325K 4K
Deferred Income Tax
n/a n/a n/a 14K
Change in Working Capital
-2.64M 4.44M -3.1M -315K
Operating Cash Flow
-79.81M -63.85M -54.6M -32.41M
Capital Expenditures
-1.25M -709K -1.09M -2.13M
Cash Acquisitions
n/a n/a 66.78K n/a
Purchase of Investments
-59.11M -233.65M -119.78M n/a
Sales Maturities Of Investments
129.18M 120.4M 53.01M n/a
Other Investing Acitivies
n/a n/a -66.78K n/a
Investing Cash Flow
68.82M -113.96M -67.87M -2.13M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.59M 1.5M 430K 334K
Financial Cash Flow
1.59M 97.29M 95.63M 166.26M
Net Cash Flow
-9.39M -80.52M -26.84M 131.72M
Free Cash Flow
-81.06M -64.56M -55.7M -34.53M